Quick Answer
ICU MEDICAL INC/DE reported Diluted EPS of $0.03 per share for fiscal year 2025.
ICU MEDICAL INC/DE Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.03 | +100.6% |
| 2024 | -$4.83 | -292.7% |
| 2023 | -$1.23 | +60.5% |
| 2022 | -$3.11 | -165.6% |
| 2021 | $4.74 | +17.9% |
| 2020 | $4.02 | -14.3% |
| 2019 | $4.69 | +252.6% |
| 2018 | $1.33 | -59.6% |
| 2017 | $3.29 | -10.1% |
| 2016 | $3.66 | +34.1% |
| 2015 | $2.73 | +62.5% |
| 2014 | $1.68 | -36.6% |
| 2013 | $2.65 | -5.4% |
| 2012 | $2.80 | -11.1% |
| 2011 | $3.15 | +45.8% |
| 2010 | $2.16 | +29.3% |
| 2009 | $1.67 | +0.0% |
| 2008 | $1.67 | +10.6% |
| 2007 | $1.51 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.14 | +89.6% | -109.8% |
| June 30, 2025 | $1.43 | +262.5% | +327.0% |
| March 31, 2025 | -$0.63 | +61.3% | +53.3% |
| September 30, 2024 | -$1.35 | -550.0% | -53.4% |
| June 30, 2024 | -$0.88 | -114.6% | +46.0% |
| March 31, 2024 | -$1.63 | -297.6% | -643.3% |
| September 30, 2023 | $0.30 | +154.5% | +173.2% |
| June 30, 2023 | -$0.41 | -32.3% | +0.0% |
- ICU MEDICAL INC/DE showed an increase of +100.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, ICU MEDICAL INC/DE’s diluted eps has declined by 98.0% (from $1.51 per share to $0.03 per share).
- The most recent figure is from ICU MEDICAL INC/DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: